Think it's time for a booster? Moderna says its newest COVID vaccine is showing signs of a stronger immune response against the virus than the current shot being offered and a longer shelf-life.
Moderna Inc. announced Tuesday that its next-generation COVID vaccine produced better immune results in a late-stage trial than its previous vaccines, and will be a key part of its combination ...
Kenya's tourism minister, clarified that while the agreement is not entirely terminated, it has been put on hold for evaluation. Moderna has stalled on purchasing land in the Tatu City economic ...
On Thursday, investment firm Jefferies updated its outlook on Moderna (NASDAQ:MRNA) shares, raising the price target to $125 from the previous $115. The firm has maintained a Hold rating on the ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
, opens new tab said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...
Covid vaccines will be sold on the high street for the first time for just under £100 to those ineligible for free jabs on the NHS. Boots is set to become the first major pharmacy to offer the ...
COVID arm is a delayed hypersensitivity reaction that occurs approximately five days after the COVID-19 vaccine. It is characterized by redness, itching, and swelling around the injection site. Unlike ...
On Thursday, investment firm Jefferies updated its outlook on Moderna (NASDAQ:MRNA) shares, raising the price target to $125 from the previous $115. The firm has maintained a Hold rating on the NASDAQ ...